Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hans J. Anders"'
Publikováno v:
Pharmacology Research & Perspectives, Vol 7, Iss 1, Pp n/a-n/a (2019)
Abstract Cisplatin is a platinum‐containing chemotherapeutic drug, which is widely used and highly effective. While effective against tumors, its use is limited by severe side effects such as nephrotoxicity and bone marrow suppression. Murine doubl
Externí odkaz:
https://doaj.org/article/842349335fb3424da11f91f8395ea66a
Autor:
Mauro M. Teixeira, Hans J. Anders, Martha Gschwandtner, Gerhild Wildner, Andreas J. Kungl, Tiziana Adage, Remo Castro Russo, Elisabeth Strutzmann, Tanja Gerlza, Maria Diedrichs-Möhring
The pro-inflammatory chemokine interleukin-8 (CXCL8) exerts its function by establishing a chemotactic gradient in infected or damaged tissues to guide neutrophil granulocytes to the site of inflammation via its G protein-coupled receptors (GPCRs) CX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::631a8e51db0c74435e1ae2fe42f224ac
https://ora.ox.ac.uk/objects/uuid:84f3f93d-618d-4f66-99df-c23c3d3b07d6
https://ora.ox.ac.uk/objects/uuid:84f3f93d-618d-4f66-99df-c23c3d3b07d6
Autor:
Bianka Marklein, Madeleine Jenning, Karen Münzner, Zoltan Konthur, Thomas Häupl, Andrew Cope, Mark Shlomchik, Hans-J Anders, Günter Steiner, Gerd R Burmester, Karl Skriner
Publikováno v:
New players and novel targets in inflammation.
Publikováno v:
Pharmacology Research & Perspectives, Vol 7, Iss 1, Pp n/a-n/a (2019)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
Cisplatin is a platinum‐containing chemotherapeutic drug, which is widely used and highly effective. While effective against tumors, its use is limited by severe side effects such as nephrotoxicity and bone marrow suppression. Murine double minute
Autor:
Ferdinand Jamitzky, Robert W. Stark, Tiandi Wei, Maciej Lech, Jing Gong, Shaila C. Rössle, Hans J. Anders, Wolfgang M. Heckl
Publikováno v:
Journal of Structural Biology. 169:323-330
Toll-like receptors (TLRs) belong to the Toll-like receptor/interleukin-1 receptor (TLR/IL-1R) superfamily which is defined by a common cytoplasmic Toll/interleukin-1 receptor (TIR) domain. TLRs recognize pathogen-associated molecular patterns and in
Autor:
Maciej Lech, Ilka Edenhofer, Maja T. Lindenmeyer, Stephan Segerer, Julie Czerkowicz, Marcus J. Moeller, Dania Rabah, Rudolf P. Wüthrich, Gitta Maria Seleznik, Jin Chen, Adrian Papandile, Nicolas Kozakowski, Kai Fu, Clemens D. Cohen, Ann Ranger, Heinz Regele, Jeffrey L. Browning, Hans J. Anders, Uriana Poreci, Judith Bauer, Harald Seeger, Nancy H. Ruddle, Mathias Heikenwalder
Publikováno v:
Kidney Int. 89, 113–126 (2015)
Accumulation of inflammatory cells in different renal compartments is a hallmark of progressive kidney diseases including glomerulonephritis (GN). Lymphotoxin β receptor (LTβR) signaling is crucial for the formation of lymphoid tissue, and inhibiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63fdba38161791b38d651bba75c5b49
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=46969
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=46969
Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy
Autor:
Clemens D. Cohen, Holger Schmid, Detlef Schlöndorff, Matthias Kretzler, Hanna Debiec, Nasim Motamedi, Andrea Ribeiro, Peter Kurktschiev, Markus Wörnle, Hans Nitschko, Hermann J. Gröne, Hans J. Anders, Elisabeth F. Gröne
Publikováno v:
Kidney international. 81(1)
Polyomavirus-associated nephropathy (PVAN) is a significant complication after kidney transplantation, often leading to premature graft loss. In order to identify antiviral responses of the renal tubular epithelium, we studied activation of the viral
Publikováno v:
Clinical transplantation. 23(1)
The recurrence of anti-glomerular basement membrane (anti-GBM) glomerulonephritis (GN) in renal transplants is very rare. We report on a patient that developed acute renal allograft dysfunction due to anti-GBM GN relapse 18 months after transplantati
Autor:
Manfred Weber, Jörg Dötsch, Said Lebbah, Simone Wygoda, Laurence Heidet, Martin Konrad, Burkhard Tönshoff, Bernd Hoppe, Pierre Cochat, Christoph Licht, Oliver Gross, Gerhard A. Müller, Lars Pape, Katharina Lange, Wolfgang Rascher, Yves Pirson, Britta Höcker, Jochen H. H. Ehrich, Hans J. Anders, Roser Torra, Patrick Niaudet, Bertrand Knebelmann, Dirk E. Müller-Wiefel, Jean-Pierre Grünfeld, Peter F. Hoyer, Tim Friede, Bodo B. Beck
Publikováno v:
Kidney International. (5):494-501
Alport syndrome inevitably leads to end-stage renal disease and there are no therapies known to improve outcome. Here we determined whether angiotensin-converting enzyme inhibitors can delay time to dialysis and improve life expectancy in three gener